Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Polycystic kidney disease (PKD) is a common cause of secondary hypertension, particularly in young people. PKD is a group of disorders, with the most relevant being autosomal dominant…
Mohamed Tinawi, MD, a nephrologist from Northwest Indiana, provides an update from Kidney Week 2023, discussing several significant studies and trials. Results from the DUPLEX trial, published in…
Michael Collins, MBChB, FRACP, PhD, a kidney transplant specialist at the Royal Adelaide Hospital, discusses his research on improving kidney transplant outcomes. He explains that during organ donation,…
Edward P.K. Kwakyi, BSc, and Rasheed A. Gbadegesin, MBBS, MD, FASN, discuss the role of apolipoprotein L1 (APOL1) in kidney diseases, particularly in people of African ancestry. APOL1…
This video includes clinical vignettes in dermatology designed to improve clinical knowledge and move through differential diagnoses quickly and efficiently.
Justin Spurr, MD, Health Miami Neuroscience, and the neurology team are conducting a study into a treatment that could benefit patients living with rheumatoid arthritis. In this study,…
Emma Rossi, MD, a gynecologic oncologist at Duke Health, discusses cervical cancer prevention and HPV. Dr Rossi explains that cervical cancer is the third most common gynecologic cancer…
Arvinder Dhalla, PhD, Rani Therapeutics; Victoria S. Ochs, BS, Indiana University School of Medicine; and Amanda Godoi, Cardiff University, discussed research findings at an ENDO 2023 press conference.…
